Home › NDC Lookup › Ingredients › Multivitamin › 59088-0201-31
🧴image loading
(from DailyMed)

LiquiCal Plus Multivitamin 1200 [iU]/mL; 2.1 mg/mL; 72 mg/mL; 252 mg/mL Liquid, 480 mL — NDC 59088-201-31 (Billing 59088-0201-31)

by PureTek Corporation · 480 mL in 1 BOTTLE

This is a package of 480 mL of LiquiCal Plus Multivitamin 1200 [iU]/mL; 2.1 mg/mL; 72 mg/mL; 252 mg/mL Liquid from PureTek Corporation, no longer marketed (first marketed Jun 2024), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 59088-0201-31
🏷️ FDA NDC (as labeled) 59088-201-31 billing pads the product segment with a zero
Rx only Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 59088-201-31 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
59088 labeler · 201 product · 31 package
Package marketed since
Jun 12, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
480 mL per package
Barcode (UPC-A, from the NDC)
3 5908820131 2
Medicaid fills, this package
24 prescriptions in the last four reported quarters
FDA record last changed
Aug 27, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Aug 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59088-201-31
Product NDC 59088-201
11-digit billing NDC 59088020131
NCPDP billing unit ML — per mL (volume)
UNII 1C6V77QF41, K72I3DEX9B, RHO26O1T9V, MLM29U2X85
SPL Set ID 1ab92efb-ae5a-b71c-e063-6294a90a60d1
Established class (EPC) Vitamin D
Chemical class Vitamin D
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Aug 2026)
Marketing start 2024-06-12
Route ORAL
Dosage form LIQUID
Substance CHOLECALCIFEROL; ZINC CITRATE; MAGNESIUM CITRATE; CALCIUM CITRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 79109904440920
GCN Seq No 086321
GCN 56017
HICL code 034092
Ingredient (HICL) Calcium Cit/Magnesium/D3/Zinc
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C1
Therapeutic class — intermediate (HIC2) Drugs Affecting Electrolyte Balance
HIC3 code C1F
Therapeutic class — specific (HIC3) Calcium Replacement
AHFS code 40:12.00.00
AHFS class Replacement Preparations
FDB label name LIQUICAL PLUS LIQUID
FDB brand name Liquical Plus
Legend status Q — Non-drug — dietary supplement, vitamin, medical food, or herbal preparation
Quick answers
  • GSN (GCN sequence number): 086321
  • GCN: 56017
  • GPI-14 (Medi-Span): 79109904440920
  • HICL (First Databank): 034092
  • AHFS class code: 40:12.00.00
Why two NDCs? The FDA registers this code as 59088-201-31 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59088-0201-31. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name LIQUICAL PLUS LIQUID Ingredient Calcium Cit/Magnesium/D3/Zinc
🧪 What is this product?

LiquiCal Plus is an oral liquid multivitamin containing calcium citrate, magnesium citrate, zinc citrate, and cholecalciferol (vitamin D). Calcium and magnesium are minerals typically used to support bone health and various metabolic functions, while zinc is commonly included in nutritional supplements for immune function and wound healing. Cholecalciferol (vitamin D) is typically used to help the body absorb calcium and maintain bone and immune health. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo $2.07 $993.60 / 480 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59088-0201-31 You're viewing this Main listing 480 mL in 1 BOTTLE 2024-06-12 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
LiquiCal Plus 1200 [iU]/mL; 2.1 mg/mL; 72 mg/mL; 252 mg/mLthis 59088-0201-31 PureTek 480 ml — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Jun 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPureTek Corporation
Labeler code59088
First marketedJun 2024
Product typeHuman Prescription Drug
Portfolio178 products on file

More NDCs from PureTek Corporation labeler code 59088

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings 🤒 Adverse Reactions 🧬 Clinical Pharmacology 📦 How Supplied / Storage and Handling 📦 Storage and Handling 📋 Description 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 34 words ▾

INDICATIONS: LiquiCal™ Plus is indicated for dietary management of patients with unique nutritional needs requiring increased Vitamin D3 and essential minerals, including Calcium, Magnesium, and Zinc in a convenient liquid form for easy administration.

⏱️ Dosage and Administration 43 words ▾

DOSAGE AND ADMINISTRATION: Shake well before use . For Children 1-3 years: 1-2 teaspoons (5-10 mL) daily For Children 4+ years: 1 tablespoon (15 mL) up to 2 times daily LiquiCal™ Plus should be administered under the supervision of a licensed healthcare practitioner.

⛔ Contraindications 38 words ▾

CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. LiquiCal™ Plus is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.

⚠️ Warnings 89 words ▾

WARNINGS AND PRECAUTIONS: Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breastfeeding. Consult your doctor.

ADVERSE REACTIONS: Adverse reactions are rare but may include gastrointestinal disturbances such as nausea or constipation. If adverse reactions occur, discontinue use and consult a healthcare professional. You should call your doctor for medical advice about serious adverse events.

To report adverse side effects or to obtain product information, contact PureTek Corporation , at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

🤒 Adverse Reactions 61 words ▾

ADVERSE REACTIONS: Adverse reactions are rare but may include gastrointestinal disturbances such as nausea or constipation. If adverse reactions occur, discontinue use and consult a healthcare professional. You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact PureTek Corporation , at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

🧬 Clinical Pharmacology 69 words ▾

CLINICAL PHARMACOLOGY Vitamin D3 is essential for calcium absorption in the gut and maintaining adequate serum calcium and phosphate concentrations, supporting bone mineralization and immune function. Calcium is crucial for the development and maintenance of healthy bones and teeth, as well as muscle function. Magnesium is important for muscle and nerve function, blood glucose control, and bone health.

Zinc supports normal growth and development, immune function, and wound healing.

📦 How Supplied / Storage and Handling 16 words ▾

HOW SUPPLIED: LiquiCal™ Plus is available in a 480 mL white HDPE bottle with NDC 59088-201-31.

📦 Storage and Handling 39 words ▾

STORAGE: KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Protect from heat, light, and moisture. Tamper Evident: Do not use if the seal is broken or missing

📋 Description 98 words ▾

DRUG DESCRIPTION: LiquiCal™ Plus Rx Only Full Prescribing Information Active Ingredients: Each 5 mL Contains: Vitamin D3 (as Cholecalciferol) ................................................................. 10 mcg (400 IU) Calcium (as Calcium Citrate) ..................................................................................... 84 mg Magnesium (as Magnesium Citrate) .........................................................................

24 mg Zinc (as Zinc Citrate) ................................................................................................ 0.7 mg Each 15 mL Contains: Vitamin D3 (as Cholecalciferol) ............................................................... 30 mcg (1200 IU) Calcium (as Calcium Citrate) ...................................................................................

252 mg Magnesium (as Magnesium Citrate) ......................................................................... 72 mg Zinc (as Zinc Citrate) ................................................................................................ 2.1 mg Other Ingredients: Agave Tequilana (Tequila Agave) Stem Extract, Aqua (Purified Water), Citric Acid, Orange Flavor, Potassium Sorbate, Xanthan Gum.

📄 Package Label / Principal Display Panel 21 words ▾

LiquiCal™ Plus Manufactured in the USA by: PureTek Corporation Panorama City, CA 91402 For questions or information call toll-free: 877-921-7873 Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q2 2025 · 2 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
24
Units reimbursed last 4 qtrs
11.5K
Gross reimbursed last 4 qtrs
$23.8K
Avg / prescription
$993.60
Avg / unit
$2.0700
Latest quarter Q2 2025
24Rx
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 24 Rx Managed care · 0 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: 11,520 units · 318 per 100k residents CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
318318
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Connecticut 318 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Multivitamin — the ingredient across all brands.

Top reported reactions

Fatigue3,698
Nausea3,253
Diarrhoea2,831
Headache2,612
Dizziness2,313
Dyspnoea2,047
Pain1,941

Age at onset

Neonate4
Infant15
Child51
Adolescent38
Adult1,015
Elderly1,062

Reporter sex

49,834 reports
Male · 34%
Female · 66%
Unknown · 0%

Serious outcomes

Hospitalization11,832
Death2,332
Disabling2,043
Life-threatening1,179
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4,407 3
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application No longer marketed (per FDA listing data)

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
PureTek Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59088-0200-54 · PureTek 59088-0202-07 · PureTek →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.